About Epixis
Epixis is a Healthcare company based in Paris (France) founded in 2003, and was acquired by VBI Vaccines in September 2011. French biotech developing e-VLP (virus like particles) immunotherapies for Hep-C. Acquired by VBI Vaccines in 2011. The company was acqui-hired. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral.
Company details
Epixis was founded in 2003 in Paris, France, as a biotechnology company. Recombinant virus-like particles were utilized in the development of immunotherapies targeting hepatitis C. The eVLP platform technology supported vaccine programs for this disease. A partnership with VBI Vaccines was formed in 2010 for a cytomegalovirus initiative. Acquisition by VBI Vaccines took place in 2011.
- Headquarters Paris, France
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website epixis.com
- Acquired by VBI Vaccines (Sep 2011)
- Investors
- Acquired byVBI Vaccines
(Sep 2011)
Investors in Epixis
Epixis has secured backing from 1 investor. Prominent investors backing the company include VBI Vaccines.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VBI Vaccines is engaged in developing vaccines and immunotherapeutics. | 2001 | vbivaccines.com | Cambridge, United States |
Investor details for Epixis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Epixis
2 dated milestones of Epixis across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Epixis is founded.
- Exit Acquired by VBI Vaccines.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Epixis
Epixis was founded in 2003.
Epixis is headquartered in Paris, France.
Epixis was founded in 2003 in Paris, France, as a biotechnology company. Recombinant virus-like particles were utilized in the development of immunotherapies targeting hepatitis C. The eVLP platform technology supported vaccine programs for this disease. A partnership with VBI Vaccines was formed in 2010 for a cytomegalovirus initiative. Acquisition by VBI Vaccines took place in 2011.
Epixis has 1 investor. Key investors include VBI Vaccines.
Yes. Epixis was acquired by VBI Vaccines in September 2011.